Product Details

Brand	Biocodex
Serving Size	2 Capsule(s)
Servings per Container	50
Form	Capsule
Product Type	Other Combinations
UPC/SKU	7 04142 00007 1
Status	On Market

Other Ingredients

Hydroxypropyl Methylcellulose other, Magnesium Stearate other

Suggested Use

Suggested use: 2 capsules 1-2 times daily

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

FDA Statement of Identity

Daily Probiotic Supplement

Formula re: Contains

Saccharomyces boulardii lyo CNCM- 1-745

100% titanium dioxide free clear capsules

Formula re: Type

For men and women

Formulation re: Does NOT Contain

Gluten-free

Non-GMO

100% titanium dioxide free clear capsules

Formulation re: Other

Appropriate for lactose intolerance Be Biotic bi-ot-ic,/bi atik/ Adjective Proactive about health Driven, confident, and strong

Unique strain with larger, stronger cells than other probiotics

Supports a immune response Strengthen digestive balance Complements your active lifestyle

Biocodex|USA

Formulation re: Vegetarian/Vegan

Vegetarian

General Statements: All Other Content

I strive to be healthy and push myself to hike new heights every day... I am Biotic

1. Swidsinski A, Loening-Baucke V, Verstraelen H, Osowska S, Doerffel Y (2008) Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology: 135(2):568-579. 2. Martins FS, Silva AA, Vieira AT, Barbosa FH, Arantes RM, et al. (2009) Comparative study of Bifidobacterium animalis, Escherichia coli, Lactobacillus casei and Saccharomyces boulardii probiotic properties. Arch Microbiol 191:623-630. 3. Klein SM, Elmer GW, McFarland LV, Surawicz CM, Levy RH (1993) Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers. Pharm Res 10:1615-1619. 4. Schneider SM, Girard-Pipau F, Filippi J, Hebuterne X, Moyse D, et al. (2005) Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition. World J Gastroenterol 11:6165-6169. 5. Buts JP, Bernasconi P, Van Craynest MP, Maldague P, De Meyer R (1986) Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res 20:192-196.

Precautions re: Children

Keep out of reach of children.

Storage

Do not refrigerate.

Suggested/Recommended/Usage/Directions